Skip to main content
SpringerLink
Log in

Colestilan, a New Bile Acid-Sequestering Resin, Reduces Bodyweight in Postmenopausal Women Who have Dieted Unsuccessfully

  • Original Research Article
  • Published:
Drugs in R & D Aims and scope Submit manuscript

Abstract

Objective: Bile acid-sequestering resins are known to be potent hypocholesterolaemic drugs, and a feeling of abdominal fullness has been reported as the most frequent adverse effect associated with their use. However, this unique adverse effect of colestilan, abdominal fullness, may have the potential to reduce total food intake. The aim of this study was to investigate the effect of colestilan, a new bile acid-sequestering resin, on the bodyweight of postmenopausal women who had previously dieted unsuccessfully.

Methods: Forty postmenopausal women who failed to diet successfully over a 4-week period were enrolled in this randomised, open-label, controlled study. Subjects were randomised to two groups: the colestilan group received four colestilan tablets administered in divided doses with three glasses of water before dinner and bedtime for 12 weeks; the control group received three glasses of water before dinner and bedtime for 12 weeks. All patients were monitored and were given the same diet instructions.

Results: Twelve weeks’ administration of colestilan in addition to diet instruction significantly reduced bodyweight and body mass index from 62.9 ± 5.7kg to 58.0 ±5.4kg (mean ± SD) and from 26.1 ± 2.0 kg/m2 to 23.9 ± 2.0 kg/m2, respectively. There were no significant differences in bodyweight before and after 12 weeks of treatment in the control group.

Conclusion: Colestilan may be useful for appetite control and exerts anti-obesity effects when used in conjunction with a weight-management programme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1

Similar content being viewed by others

References

  1. Anderson JW, Konz EC. Obesity and disease management: effects of weight loss on comorbid condition. Obes Res 2001; 9 Suppl. 4: 326S–34S

    Article  PubMed  Google Scholar 

  2. Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr 1991; 53: 595S–603S

    Google Scholar 

  3. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–9

    Article  PubMed  CAS  Google Scholar 

  4. National Institutes of Health, National Heart, Lung and Blood Institutes. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998; 6 Suppl. 2: 51S–209S

    Google Scholar 

  5. Schwartz RS. Obesity in the elderly: handbook of obesity. In: Bray GA, Bouchard C, James WPT, editors. New York: Marcel Dekker, 1998: 103–114

  6. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994; 18: 207–11

    PubMed  CAS  Google Scholar 

  7. Ley C, Lee JB, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992; 55: 950–4

    PubMed  CAS  Google Scholar 

  8. Milewicz A, Tworowska U, Demissie M. Menopausal obesity: myth or fact. Climacteric 2001; 4: 273–83

    PubMed  CAS  Google Scholar 

  9. Glazer G. Long-term pharmacotherapy of obesity 2000. Arch Intern Med 2001; 161: 1814–24

    Article  PubMed  CAS  Google Scholar 

  10. Mitsubishi Chemical Corporation. MCl-196, bile acid sequestrant. Drugs Future 1993; 18: 15–7

    Google Scholar 

  11. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677–85

    Article  PubMed  CAS  Google Scholar 

  12. Blundell JE, Gillett A. Control of food intake in the obese. Obes Res 2001; 9 Suppl. 4: 263S–70S

    Article  PubMed  CAS  Google Scholar 

  13. French SJ, Murray B, Rumsay RD, et al. Adaptation to high fat diets; effect on eating behavior and plasma cholesystokinin. Br J Nutr 1995; 73: 179–89

    Article  PubMed  CAS  Google Scholar 

  14. Havel PJ, Townsend R, Chaump L, et al. High-fat meals reduce 24-h circulating concentrations in women. Diabetes 1999; 48: 334–41

    Article  PubMed  CAS  Google Scholar 

  15. Schrauwen P, Westerterp KR. The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr 2000; 84: 417–27

    Article  PubMed  CAS  Google Scholar 

  16. Blundel JE, Macdiarmid JI. Passive overconsumption: fat intake and short-term energy balance. Ann N Y Acad Sci 1997; 827: 392–407

    Article  Google Scholar 

  17. Blundell JE, Lawton CL, Cotton JR, et al. Control of human appetite: implications for the intake of dietary fat. Annu Rev Nutr 1996; 16: 285–319

    Article  PubMed  CAS  Google Scholar 

  18. Homma Y, Goto Y, Okajima S, et al. Effect of treatment with MCI-196, a new bile acid sequestering resin on plasma lipids and apolipoproteins in type II hyperlipoproteinemia. Nutr Metab Cardiovasc Dis 1996; 6: 211–6

    CAS  Google Scholar 

  19. Daittilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 302–8

    Google Scholar 

  20. Anderson JW, Brinkman-Kaplan VL, Lee H, et al. Relationship of weight loss to cardiovascular risk factors in morbidly obese individuals. J Am Coll Nutr 1994; 14: 256–61

    Google Scholar 

  21. Busetto L. Visceral obesity and the metabolic syndrome: effects of weight loss. Nutr Metab Cardiovasc Dis 2001; 11: 195–204

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science to Dr Koike.

The authors have no potential conflicts of interest that are directly relevant to the contents of this article.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan

    Koji Koike, Kouichi Murakami, Noriko Nozaki & Masaki Inoue

  2. Sugiura Clinic, Hikarigaoka, Kanazawa, Ishikawa, Japan

    Kouichi Sugiura

Authors
  1. Koji Koike
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kouichi Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noriko Nozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kouichi Sugiura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masaki Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koji Koike.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koike, K., Murakami, K., Nozaki, N. et al. Colestilan, a New Bile Acid-Sequestering Resin, Reduces Bodyweight in Postmenopausal Women Who have Dieted Unsuccessfully. Drugs R D 6, 273–279 (2005). https://doi.org/10.2165/00126839-200506050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200506050-00003

Keywords

Search

Navigation